As the age-related differences in TDLN and tumor-infiltrating CD11c+ cells and T cells reported in this study were observed after one-third of the usual IL-2/CD40 schedule, further studies are required to examine CD11c+ cells/DCs and T cells after a complete schedule of IL-2/CD40. This evidence concerns the gene CD40 and neoplasm.